Aggressive NK Cell Leukemia - 24 Studies Found

Recruiting : CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
:
  • Acute Myeloid Leukemia
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • Adult Lymphocyte Predominant Hodgkin Lymphoma : 2014-06-18
    :
    • Drug: 6,8-bis(benzylthio)octanoic acid

Completed : Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma : 2013-10-08
    :
    • Drug: busulfan Given IV

Recruiting : Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Myeloid Leukemia With 11q23 (MLL)
    : 2013-04-22
    :
    • Biological: therapeutic allogeneic lymphocytes

Recruiting : Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma : 2013-02-27
    :
    • Drug: brentuximab vedotin Give
Recruiting : Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma : 2013-02-13
    :
    • Other: questionnaire administration

Withdrawn : Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
:
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • AIDS-related Diffuse Large Cell Lymphoma

    • : 2013-01-15
    :
    • Drug: carmustine Given IV
Terminated : Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer
:
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • : 2013-01-14
    :
    • Biological: Ipilimumab Given i
Recruiting : Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    : 2013-01-02
    :
    • Drug: Fludarabine phosphate Gi
Completed : MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
:
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • : 2012-12-11
    :
    • Biological: anti-endosialin/TEM1 monoclonal antibody MORAb-004

<<< Previous | Next >>>